Immunotherapy Access From Districts of Telangana and Andhra Pradesh — Warangal, Karimnagar and Beyond

The infusion is given as day care at a CION centre. The centres section further down this page lists every location with a direct phone number — call the closest one and ask whether it runs day-care immunotherapy, and which medical oncologist would own your course. The answer differs by district and by drug.

That is the honest starting point, and it is worth understanding why it cannot be a single address. Immunotherapy is not one event in one building. It is four different things happening in three different places, and only one of them actually requires you to travel. Families who plan around the infusion alone are usually surprised by the reviews and the scans; families who understand the whole shape of it plan far better.

Two questions settle the choice of centre faster than any distance calculation. “Which medical oncologist is responsible for my course, and how often will I see that person?” and “If I develop a problem on a Sunday in my district, who do I call and which hospital admits me?” A centre that answers both in writing has told you most of what you need to know. If the answer points somewhere other than CION, that is a legitimate outcome of the question.

You travel for the infusion day. Checkpoint inhibitor schedules commonly run every three weeks, with some regimens given every two, four or six weeks — your oncologist sets the interval by drug and dose. Compared with radiotherapy, which can mean travelling every weekday for weeks, that is one planned trip per cycle.

The infusion itself is short — typically well under an hour of drip time, with preparation, observation and paperwork around it. Most people go home the same afternoon and back to ordinary work within a day or two. It is worth planning the first cycle more generously than the rest: you will be watched for longer afterwards, the paperwork takes time, and nobody should be making a three-hour journey while still working out how they feel.

Where the arithmetic still does not work — the journey is too long, or the family cannot spare the accompanying person every cycle — the answer is not to quietly skip cycles. It is to redesign the plan with your oncologist, which usually means moving monitoring closer to home rather than moving the infusion. Shared Care: Infusion in the City, Monitoring Near Home sets out how that arrangement is written and who stays responsible for what.

At a local laboratory or hospital your treating team agrees to in advance. The usual pre-cycle panels are a full blood count, liver and kidney function, and thyroid function. What makes local monitoring safe is not the lab — it is the written plan saying which tests, when, where the report goes, and what triggers a phone call.

This is the part families under-negotiate. A monitoring arrangement that exists only as a verbal “get your bloods done there and bring them” is the arrangement that fails, because nobody local knows what an abnormal result means on this treatment and nobody at the centre sees the report until you arrive. Five things have to be on paper before it works.

• Which tests, and how many days before the cycle. Named panels with a timing window, so the results are in hand before you set out rather than after you have travelled.
• Where the report is sent, and by whom. A named person, a number or an email address at the treating centre — and a copy that stays with you, not only with the lab.
• Which results mean stop and phone. Written thresholds for the counts, liver enzymes, kidney function and thyroid results that mean call before travelling instead of turning up for the cycle.
• Which symptoms mean call immediately, whatever the blood tests say. Loose motions that keep going, a new cough or breathlessness, chest pain or palpitations, severe weakness or confusion. These are not wait-and-watch symptoms on immunotherapy.
• Who answers at night and on Sunday, and which hospital admits you. A number that reaches a clinician out of hours, and a named local hospital that has agreed in advance to take you, in writing.

All of that has to travel with you as paper, because the doctor who sees you at 2 am in a district hospital will not have access to the treating centre’s records. Getting Your Treatment Records and Reports covers exactly what to ask for after every cycle and how to keep it usable.

Work backwards from the infusion. Bloods a few days before, results confirmed before you leave, an early start, the review and infusion on the same visit, and the paperwork in your hand before you go home. Done in that order, most families make a single round trip per cycle.

1. 1

   Get the bloods done at home, a few days ahead

   Use the local laboratory agreed with your team, within the window they gave you. Ask the lab to send the report to the centre the same day, and take a printed copy yourself.

2. 2

   Confirm the cycle before you travel

   Call the centre once the results are in. A cycle is occasionally postponed on a blood result, and a phone call the evening before saves a wasted journey for two people.

3. 3

   Carry the file, not just the memory

   Prescription, previous cycle dates, drug name and dose, recent reports and any medicine list. If someone else is accompanying you this time, they need the file to answer for you.

4. 4

   Plan the review and the infusion as one visit

   Ask for the pre-cycle review to be scheduled on the infusion day itself. Two separate trips for one cycle is the most common avoidable cost in a district plan.

5. 5

   Expect the day to be longer than the drip

   The infusion is short; registration, review, pharmacy and observation are not. For a first cycle, assume the whole day and do not book a late journey back.

6. 6

   Leave with paperwork, every single time

   Drug name, dose, batch, date, the next cycle date and any change to the plan — in writing. This is what makes local care possible for the next three weeks.

7. 7

   Fix the next date and the next blood test before you leave

   Book both together. A cycle date without a matching local blood-test date is how the next journey turns into two.

Ask for the written instructions in the language the family actually reads at home. A discharge note that the person doing the caring cannot read is an instruction that will not be followed, and across Telangana and Andhra Pradesh that is far more often a Telugu question than an English one.

One page that any doctor can act on: the drug name, the dose, the date of the last cycle, the treating oncologist’s number, and the sentence that this patient is on immunotherapy. That single page is what makes a district hospital think of an immune side effect instead of an infection.

Immune-related side effects do not announce themselves as cancer-treatment problems. They arrive as loose motions, a cough, tiredness, a racing heart or a headache — the same symptoms a doctor sees fifty times a week from ordinary causes. The difference is entirely in knowing that the patient is on a checkpoint inhibitor, and that difference has to be carried in your hand, because a doctor in another town cannot open the treating centre’s file.

A note on what is not ours to give, because district families are sometimes sent a long way for it. CION does not provide CAR-T or any other cell therapy, at any centre, and does not stock CAR-T product. That treatment needs apheresis, a licensed cell-processing facility, intensive care and a team trained in cytokine release syndrome. If it has been raised for you, the next step is a referral to a licensed cell-therapy centre. Be wary of any unit offering it alongside routine day care, or of clinics offering unproven immune infusions under similar-sounding names.

If treatment has already started somewhere else and travel has become the reason it is faltering, moving it is a normal, planned process rather than a fresh start. Transferring Immunotherapy Treatment to Another Centre sets out what has to move with you and what should never be interrupted while it does.

Access from a district comes down to three practical questions and one overview: how monitoring is shared with a local team, what paperwork you are entitled to after every cycle, and how treatment moves if the arrangement stops working. These pages take each one in turn.

• Shared Care: Infusion in the City, Monitoring Near Home — how the arrangement is written, who stays responsible for the course, and the four conditions without which it does not work.
• Getting Your Treatment Records and Reports — what to ask for after every cycle, and how to keep it in a form a district hospital can act on at night.
• Transferring Immunotherapy Treatment to Another Centre — what has to move with you, what must not be interrupted, and how to time it between cycles.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment, monitoring and escalation fit together as one pathway.

Two things worth saying plainly at the end. Not starting immunotherapy is a legitimate option, and so is being treated somewhere other than here — if the nearest capable centre for your family is not one of ours, that is the right answer and we would rather you heard it now than halfway through. And the cost of travel is a real cost: transport, lost earnings for whoever accompanies the patient, sometimes accommodation, repeated over many months. Every such figure is indicative, as of August 2026, and different for every family. Put yours into the conversation before the first cycle, not after the fourth.

Get the Travel and Monitoring Plan in Writing

Bring your reports. We will set out the cycle interval, which tests can be done locally and who to call at night — so the plan works from your district, not only from Hyderabad.